Virus News and Research

Latest Virus News and Research

First meeting of the International Health Regulations Emergency Committee reports on mpox surge

The Director-General of the World Health Organization (WHO), having concurred with the advice offered by the International Health Regulations (2005) (IHR or Regulations) Emergency Committee regarding the upsurge of mpox 2024 during its first meeting, held on 14 August 2024, has determined, on the same date, that the ongoing upsurge of mpox in the Democratic Republic of the Congo (DRC) and in a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the provisions of the Regulations.

20 Aug 2024

Global and Local Efforts to Take Action Against Hepatitis

In this interview, we explore global and local efforts to combat viral hepatitis with Lindsey Hiebert, Deputy Director of the Coalition for Global Hepatitis Elimination (CGHE), and James Amugsi, a Mandela Washington Fellow and Physician Assistant at Sandema Hospital in Ghana. Together, they provide valuable insights into the challenges, successes, and the importance of partnerships in the fight against hepatitis.

20 Aug 2024

Study reveals how avian flu adapts to mammalian cells

In recent years, public health measures, surveillance, and vaccination have helped bring about significant progress in reducing the impact of seasonal flu epidemics, caused by human influenza viruses A and B.

19 Aug 2024

Long COVID symptoms may stem from low cortisol and altered brain immune response

Proteins left behind by COVID-19 long after initial infection can cause cortisol levels in the brain to plummet, inflame the nervous system and prime its immune cells to hyper-react when another stressor arises, according to new animal research by University of Colorado Boulder scientists.

19 Aug 2024

APOE ε4 carrier status increases the long-term cognitive decline risk associated with herpes zoster

The long-term subjective cognitive decline risk associated with Herpes zoster infections.

19 Aug 2024

New insights into COVID-19 spike protein offer hope for universal vaccines

A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers Center at the Center for Theoretical Biological Physics (CTBP) at Rice, has made a discovery in the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19.

16 Aug 2024

Understanding host immune responses through cell death pathways

A new review was published as the cover paper of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science), Volume 16, Issue 15, entitled, "Types of cell death and their relations to host immunological pathways".

16 Aug 2024

Tecovirimat shows no significant impact on mpox lesion duration in DRC study

The antiviral drug tecovirimat did not reduce the duration of mpox lesions among children and adults with clade I mpox in the Democratic Republic of the Congo (DRC), based on an initial analysis of data from a randomized, placebo-controlled trial.

16 Aug 2024

Infections drive brain volume loss and dementia risk by altering key immune proteins, study reveals

Severe infections are linked to increased brain atrophy, particularly in the temporal lobe, which may elevate dementia risk through immune-related proteins.

15 Aug 2024

WHO declares international health emergency as mpox spreads rapidly in Africa

WHO has declared the upsurge of mpox in the DRC and other African countries as a public health emergency of international concern, citing its potential for further spread and the urgent need for coordinated global action.

15 Aug 2024

Unusual surge in children's pneumonia cases in England linked to Mycoplasma pneumoniae

Study reveals a significant and prolonged rise in pneumonia-related emergency visits among children in England, driven primarily by Mycoplasma pneumoniae infections during the winter of 2023-24.

15 Aug 2024

Study finds no clinically useful biomarkers for long COVID in routine lab tests

Whether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC).

14 Aug 2024

COVID-19 vaccine rollout phases linked to decreased anxiety and depression in US adults

The various COVID-19 vaccine rollout phases impacted the prevalence of depression and anxiety at the population level among adults in the country.

14 Aug 2024

New targets for improved cancer immunotherapy

In the past two decades, immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, showing promising results against various solid tumors. This study reviews recent developments in ICIs, focusing on new targets like T cell immunoreceptors with Ig and ITIM domains (TIGIT), T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3), and lymphocyte activation gene-3 (LAG-3). These targets aim to overcome resistance mechanisms limiting the effectiveness of current therapies, such as anti-PD-1 and anti-CTLA-4. By identifying and developing these new ICIs, researchers hope to improve treatment outcomes and provide new therapeutic options for cancer patients.

14 Aug 2024

Novel vaccination strategy shows promise in boosting immunity and controlling influenza spread in pigs

Study demonstrates that a novel prime/boost vaccination protocol using live-attenuated influenza vaccines effectively induces strong immune responses in pigs, offering a promising approach for future influenza vaccination strategies.

13 Aug 2024

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

This review offers an in-depth exploration of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL), highlighting its distinct characteristics across various domains such as epidemiology, clinical presentation, histopathology, immunophenotype, genetic findings, and challenges in differential diagnosis.

13 Aug 2024

Lurie Children's and University of Utah Health receive $12 million for study on antibiotic use in pediatric pneumonia

Ann & Robert H. Lurie Children's Hospital of Chicago, in partnership with University of Utah Health, has been approved for $12 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI) for a study that will compare two ways to use antibiotics in young children with mild pneumonia, one of the leading reasons children seek acute care, who are well enough to be cared for at home.

13 Aug 2024

WHO considers declaring mpox outbreak a Public Health Emergency of International Concern

Previous
1
...
46
47
48
49
50
51
52
...
1572
Next

Virus News and Research

Latest Virus News and Research

First meeting of the International Health Regulations Emergency Committee reports on mpox surge

Global and Local Efforts to Take Action Against Hepatitis

Study reveals how avian flu adapts to mammalian cells

Long COVID symptoms may stem from low cortisol and altered brain immune response

APOE ε4 carrier status increases the long-term cognitive decline risk associated with herpes zoster

New insights into COVID-19 spike protein offer hope for universal vaccines

Understanding host immune responses through cell death pathways

Tecovirimat shows no significant impact on mpox lesion duration in DRC study

Infections drive brain volume loss and dementia risk by altering key immune proteins, study reveals

WHO declares international health emergency as mpox spreads rapidly in Africa

Unusual surge in children's pneumonia cases in England linked to Mycoplasma pneumoniae

Study finds no clinically useful biomarkers for long COVID in routine lab tests

COVID-19 vaccine rollout phases linked to decreased anxiety and depression in US adults

New targets for improved cancer immunotherapy

Novel vaccination strategy shows promise in boosting immunity and controlling influenza spread in pigs

Exploring the distinct characteristics of Nodular Lymphocyte Predominant Hodgkin Lymphoma

Lurie Children's and University of Utah Health receive $12 million for study on antibiotic use in pediatric pneumonia

WHO considers declaring mpox outbreak a Public Health Emergency of International Concern

NIH study finds routine lab tests fall short in diagnosing long COVID

Study uncovers OLAH as key driver of fatal respiratory disease

A new way of characterising biomolecules eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in